Literature DB >> 16275485

Opportunity of detecting pre-hypertension: worldwide data on blood pressure overswinging.

G Cornélissen1, A Delcourt, G Toussaint, K Otsuka, Y Watanabe, J Siegelova, B Fiser, J Dusek, P Homolka, R B Singh, A Kumar, R K Singh, S Sanchez, C Gonzalez, D Holley, B Sundaram, Z Zhao, B Tomlinson, B Fok, M Zeman, K Dulkova, Franz Halberg.   

Abstract

Overswinging or CHAT (brief for Circadian Hyper-Amplitude-Tension), that is an excessive circadian variation in blood pressure (BP), has been associated with a large increase in cardiovascular disease risk, present even in the absence of an elevated BP itself. This usually asymptomatic condition is usually overlooked by current practice based on spot-checks, because to be diagnosed, measurements need to be taken around-the-clock, preferably for 7 days at the outset. Once diagnosed, however, a usual circadian BP pattern can be restored by means of certain non-pharmacologic or pharmacologic interventions timed appropriately. Thereby, it is possible to reduce the risk of cardiovascular morbidity and mortality, cerebral ischemic events and nephropathy in particular. For the preparation of guidelines regarding the diagnosis of BP disorders and for the institution of primary as well as secondary preventive measures, it is important to know what the incidence of CHAT is on a global basis. We found 191 cases of CHAT among 1602 mostly 7-day/24-h BP profiles, obtained from several centers in different countries participating in an ongoing project on the BIOsphere and the COSmos (BIOCOS). CHAT incidence is about the same between men and women, but it is diagnosed more often among patients with borderline hypertension or with glucose intolerance. It is also more common among MESOR-hypertensive than among MESOR-normotensive individuals. Priority should be given to the development of an unobtrusive and affordable device to automatically monitor BP and to analyze the data as-one-goes, so that cardiovascular disease risk can be prevented.

Entities:  

Mesh:

Year:  2005        PMID: 16275485      PMCID: PMC2581881          DOI: 10.1016/s0753-3322(05)80023-x

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  7-day ambulatory monitoring for adults with hypertension and diabetes.

Authors:  G Cornélissen; O Schwartzkopff; F Halberg; K Otsuka; Y Watanabe
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

2.  Effects of autogenic training and antihypertensive agents on circadian and circaseptan variation of blood pressure.

Authors:  Yoshihiko Watanabe; Germaine Cornélissen; Misako Watanabe; Fumihiko Watanabe; Kuniaki Otsuka; Shi-ichiro Ohkawa; Takenori Kikuchi; Franz Halberg
Journal:  Clin Exp Hypertens       Date:  2003-10       Impact factor: 1.749

3.  Chronobiometric assessment of autogenic training effects upon blood pressure and heart rate.

Authors:  Y Watanabe; F Halberg; G Cornélissen; Y Saito; K Fukuda; K Otsuka; T Kikuchi
Journal:  Percept Mot Skills       Date:  1996-12

4.  Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy.

Authors:  K Otsuka; G Cornélissen; F Halberg; G Oehlerts
Journal:  J Med Eng Technol       Date:  1997 Jan-Feb

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Blood pressure outcomes of dental patients screened chronobiologically: a seven-year follow-up.

Authors:  E M Schaffer; G Cornélissen; N Rhodus; M Halhuber; Y Watanabe; F Halberg
Journal:  J Am Dent Assoc       Date:  2001-07       Impact factor: 3.634

7.  Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.

Authors:  P Verdecchia; G Schillaci; M Guerrieri; C Gatteschi; G Benemio; F Boldrini; C Porcellati
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

8.  Impact of circadian amplitude and chronotherapy: relevance to prevention and treatment of stroke.

Authors:  M Shinagawa; Y Kubo; K Otsuka; S Ohkawa; G Cornélissen; F Halberg
Journal:  Biomed Pharmacother       Date:  2001       Impact factor: 6.529

Review 9.  100 or 30 years after Janeway or Bartter, Healthwatch helps avoid 'flying blind'.

Authors:  Germaine Cornélissen; Franz Halberg; Earl Bakken; Ram B Singh; Kuniaki Otsuka; Brian Tomlinson; Alain Delcourt; Guy Toussaint; Srilakshmi Bathina; Othild Schwartzkopff; Zhengrong Wang; Roberto Tarquini; Federico Perfetto; Giancarlo Pantaleoni; Rita Jozsa; Patrick A Delmore; Ellis Nolley
Journal:  Biomed Pharmacother       Date:  2004-10       Impact factor: 6.529

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

  10 in total
  6 in total

1.  Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults.

Authors:  Jerome L Abramson; Cheryl Lewis; Nancy V Murrah; Grant T Anderson; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2006-07-07       Impact factor: 2.778

2.  Cancer chronomics I. Origins of timed cancer treatment: early marker rhythm-guided individualized chronochemotherapy.

Authors:  Franz Halberg; Konald Prem; Francine Halberg; Catherine Norman; Germaine Cornélissen
Journal:  J Exp Ther Oncol       Date:  2006

3.  ANALYSIS OF BAROREFLEX FUNCTION BY MEANS OF MATHEMATICAL MODEL.

Authors:  B Fišer; J Siegelová; M Pohanka; M Mašek; J Barák; J Moudr; C Cornélissen; F Halberg
Journal:  Scr Med (Brno)       Date:  2007-10-01

Review 4.  Schedule shifts, cancer and longevity: good, bad or indifferent?

Authors:  Germaine Cornélissen; Julia Halberg; Franz Halberg; Salvador Sanchez de la Pena; Walter Nelson; Othild Schwartzkopff; Alexander Stoynev; Erhard Haus
Journal:  J Exp Ther Oncol       Date:  2008

Review 5.  Role of Remote Navigation Systems in AF Ablation.

Authors:  Boris Schmidt; Britta Schulte-Hahn; Bernd Nowak; Verena Windhorst; Verena Windhorst; Kyoung Ryul Julian Chun
Journal:  J Atr Fibrillation       Date:  2011-02-22

6.  Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Gracilariopsis lemaneiformis (Rhodophyta) in Spontaneously Hypertensive Rats (SHRs).

Authors:  Zhenzhen Deng; Yingjuan Liu; Jing Wang; Suhuang Wu; Lihua Geng; Zhenghong Sui; Quanbin Zhang
Journal:  Mar Drugs       Date:  2018-08-27       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.